Eloxx Pharmaceuticals, Inc.NASDAQ: ELOX

ELOX: Sixth Amendment adds bridge and Tranche 2 loans, PIK interest, and new agent SD MF 4 LLC

· Issued by Eloxx Pharmaceuticals, Inc.

The Sixth Amendment to the Loan and Security Agreement, effective July 10, 2024, introduces a bridge loan, a new Tranche 2 Advance, and allows for payment-in-kind interest and optional or mandatory debt-to-equity conversion in a qualified financing. SD MF 4 LLC replaces Hercules as agent, and the amendment includes a broad release of claims and updated collateral arrangements.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Eloxx Pharmaceuticals, Inc. on 6ix

Earlier from Eloxx Pharmaceuticals

Later from Eloxx Pharmaceuticals

All Eloxx Pharmaceuticals news releases